410
clinical trials and growing...

CNS/Psychiatry

Encorium has completed 59 studies on 3,800 patients on 37 sites. Our extensive operation in Scandinavia supports studies in depression. Studies include:

  • ADHD
  • Allergic symptoms (antihistamines effect on driving)
  • Alzheimer 
  • Bipolar disorder
  • Depression
  • Epilepsy (Unverricht-Lunborg disease)
  • Insomnia
  • Major depressive disorder
  • Migraine
  • Multiple sclerosis
  • Myasthenia gravis
  • Pain (incl. polyneuropathic)
  • Parkinson’s disease
  • Schizophrenia
  • Sub-arachnoid haemorrhage

Go back to Therapeutic Areas »

Contact Us

For enquiries on Encorium's services and capabilities, please contact info@encorium.com alternatively contact your local Encorium operations (see the site location map).

Encorium Headquarter

Encorium Oy
Keilaranta 10
FI-02150 Espoo
Finland
Tel: +358 20 751 8200
Fax:
Clinical Department
+358 20 751 8250
Administration
+358 20 751 8255
info@encorium.com